http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20020003568-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C229-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C279-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C259-06 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C279-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C259-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-08 |
filingDate | 2000-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2002-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20020003568-A |
titleOfInvention | Novel hydroxamic acid derivatives |
abstract | The present invention provides a compound which is not only high in metalloproteinase inhibitory activity but also improves drug or biological activity in a living body such as oral absorption, useful as a medicament, an intermediate for producing the same, and a method for producing the same. Compounds of formula (I) or salts thereof are useful as medicinal and / or veterinary compositions, particularly metalloproteinase inhibitors that inhibit matrix metalloproteinases and / or tumor necrosis factor-α (TNF-α) converting enzymes. .n n n Formula In n n n n n n n In the above formula, R 1 , R 2 , R 3 , R 5 , R 6 , R 7 , R 8 represent hydrogen and the like, and R 4 represents an alkyl group and the like. |
priorityDate | 1999-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 321.